Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure

Lim, Sean H. and Johnson, Peter W.M. (2011) Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure. Nature Reviews Clinical Oncology, 8, (11), 634-636. (doi:10.1038/nrclinonc.2011.137). (PMID:21894205).


Full text not available from this repository.


The combination of doxorubicin, bleomycin, vincristine and dacarbazine (ABVD) has emerged as a standard of care in advanced-stage Hodgkin lymphoma over the past four decades. Clinicians treating patients with cancer frequently walk a tightrope where the requirements of efficacy have to be balanced against the morbidity caused by the treatment.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1038/nrclinonc.2011.137
ISSNs: 1759-4774 (print)
1759-4782 (electronic)
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
Divisions : Faculty of Medicine > Cancer Sciences
ePrint ID: 340837
Accepted Date and Publication Date:
November 2011Published
Date Deposited: 04 Jul 2012 10:35
Last Modified: 31 Mar 2016 14:30

Actions (login required)

View Item View Item